comparemela.com

Latest Breaking News On - Anaptysbio inc - Page 1 : comparemela.com

GSK : New data at ASCO showcases the transformational potential of GSK's oncology portfolio

DREAMM-8 results for Blenrep in multiple myeloma featured in a late-breaking presentation and ASCO s Press Programme Updated results from a supported.

China
United-kingdom
Macau
United-states
Hong-kong
Taiwan
Japan
Chicago
Illinois
Japanese
Chinese
American

Anaptys Taps $50M From Sagard Deal - San Diego Business Journal

Anaptys Taps $50M From Sagard Deal - San Diego Business Journal
sdbj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sdbj.com Daily Mail and Mail on Sunday newspapers.

San-diego
California
United-states
Ali-alagheband
Daniel-faga
Nasdaq
Anaptysbio-inc
Sagard-healthcare
Anaptys-discovered-jemperli
Anaptysbio-president

Wedbush Comments on AnaptysBio, Inc.'s Q1 2025 Earnings (NASDAQ:ANAB)

Wedbush Comments on AnaptysBio, Inc.'s Q1 2025 Earnings (NASDAQ:ANAB)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Ericj-loumeau
Leerink-partnrs
Daniel-faga
Stifel-nicolaus
Anaptysbio-inc
First-light-asset-management
Great-point-partners
Nasdaq
Securities-exchange-commission
Jpmorgan-chase-co
Franklin-resources-inc
Eventide-asset-management

AnaptysBio (NASDAQ:ANAB) Earns Outperform Rating from Wedbush

AnaptysBio (NASDAQ:ANAB) Earns Outperform Rating from Wedbush
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

China
Daniel-faga
Leerink-partnrs
Piper-sandler
Zurcher-kantonalbank-zurich-cantonalbank
Ericj-loumeau
Stifel-nicolaus
China-universal-asset-management-co
Quest-partners
Anaptysbio-inc
Securities-exchange-commission
Sg-americas-securities

vimarsana © 2020. All Rights Reserved.